Ravishankar Iyer, author of Story Rules, transforms data-heavy presentations into compelling narratives that drive business ...

How are data and AI being used to deliver value to customers and employees in the insurance industry? This is among the ...

From the written to the visual, from much-maligned data-heavy PowerPoint presentations to humorous hooks, the author lays out ...

To prepare AI agents for office work, the company is asking contractors to upload projects from past jobs, leaving it to them ...

London, UK – 9 th December 2025. Actimed Therapeutics Ltd (“Actimed”), a UK based clinical stage specialty pharmaceutical company focused on bringing innovation to the treatment of cancer cachexia and ...

ReSPECT-Glioblastoma (GBM) trial of REYOBIQ as a novel therapeutic for recurrent GBM demonstrated promising safety and efficacy signal, supporting continued Phase 2 enrollment and investigation MRI ...

IRVINE, Calif., Nov. 20, 2025 /PRNewswire/ -- PeproMene Bio, Inc., a clinical-stage biotechnology company developing novel therapies for relapsed and refractory (r/r) B-cell malignancies, announced ...

PE giant Vista Equity Partners plans to reduce staff head count as it adopts artificial intelligence tools across its firm and portfolio, a move that highlights tensions between efficiency drives and ...

The MarketWatch News Department was not involved in the creation of this content. Poster Presentation on VENTURE Study Results Evaluating Impact of VK2735 on Prediabetes and Cardiometabolic Status ...

Preclinical data on PN-881, a first-in-class oral peptide targeting the IL-17 pathway and fully owned by Protagonist, are also being presented at EADV. 3 The Company expects that the first subject ...

Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event rates to placebo in Phase 3 ICONIC-ADVANCE studies Icotrokinra also showed ...